Nakagawa H, Nagasaka A, Sugiura T, Nakagawa K, Yabe Y, Nihei N, Hirooka M, Itoh M, Nakai A, Ohyama T
Horm Metab Res. 1985 Oct;17(10):522-7. doi: 10.1055/s-2007-1013594.
The case of a 16 year-old boy with McCune-Albright's syndrome which is rarely accompanied by gigantism was studied endocrinologically. The stimulation of growth hormone (GH) release by hypoglycemia, the decline of elevated GH by hyperglycemia and a little lower somatostatin like immunoreactivity (SLI) may support abnormalities of hypothalamic function, but the existence of pituitary microadenoma cannot be ruled out because of the paradoxical suppression of GH release by oral administration of bromocriptine (CB-154) and L-DOPA and the stimulation of GH release by intravenous administration of TRH.
对一名患有麦库恩-奥尔布赖特综合征且极少伴有巨人症的16岁男孩进行了内分泌学研究。低血糖对生长激素(GH)释放的刺激、高血糖导致升高的GH下降以及稍低的生长抑素样免疫反应性(SLI)可能提示下丘脑功能异常,但由于口服溴隐亭(CB-154)和左旋多巴时GH释放出现矛盾性抑制,以及静脉注射促甲状腺激素释放激素(TRH)时GH释放受到刺激,因此不能排除垂体微腺瘤的存在。